home       Kontakt       Disclaimer

Praxis | Labor    Aeschenvorstadt 57    CH-4053 Basel

Endokrinologie
Diabetologie
Osteologie

Praxis

Labor

Patienten

Publikationen

Forschung

Aktuelles

Titel Bild: 2011

Publikationen

2018        2017        2016        2015        2014        2013        2012        2011        2010        2009        2008

Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R.
Use of metformin and the risk of ovarian cancer: a case-control analysis

Gynecol Oncol 2011, 123: 200-204

Dimai H.P., Meier C.
Osteoporose des Mannes

Der informierte Arzt (2011), 4: 31-34

Dürsteler-MacFarland K.M., Kowalewski R., Bloch N., Wiesbeck G.A., Kraenzlin M., Stohler R.
Patients on injectable diacetylmorphine maintenance have low bone mass

Drug Alcohol Rev (2011), 30: 577-582

Kraenzlin M.E., Meier C.
Parathyroid hormone analogues in the treatment of osteoporosis.

Nature Rev Endocrinol. 2011;7:647-656

Kraenzlin M.E., Meier C.,
Schlaglichter 2010: Neue Wege in der Diagnostik und Therapie der Osteoporose

Swiss Med Forum (2011), 11: 25-28

Kraenzlin M.E., Meier C.
Schlaglichter 2010: Neue Wege in der Diagnostik und Therapie der Osteoporose. Replik

Swiss Med Forum (2011), 11: 325

Kraenzlin M.E., Suter-Widmer I., Meier C.
Sekundäre Osteoporosen

Der informierte Arzt (2011), 4: 26-31

Kraenzlin M.E., Meier C.
Kalzium-Metabolismus: Einige physiologische Bemerkungen

Spectrum Osteoporose (2011), 2: 8-10

Lamy O., Kraenzlin M.
Osteoporosis: evaluation and fracture risk

Rev Med Suisse (2011), 7: 1018-1019

Meier C., Kraenzlin M.E.
Antiepileptics and bone health

Ther Adv Musculoskelet Dis (2011), 3: 235-243

Meier C., Kraenzlin M.E.
Calcium supplementation, osteoporosis and cardiovascular disease

Swiss Med Wkly (2011), 141: w13260

Meier C., Kraenzlin M.E.
Epilepsie, Antiepileptika und Osteoporose

Epileptologie (2011), 28: 42-50

Meier C., Kraenzlin M.E.
Kathepsin K-Inhibitoren in der Osteoporosetherapie

Osteologie (2011), 20: 211-216

Meyer U., Romann M., Zahner L., Schindler C., Puder J.J., Kraenzlin M., Rizzoli R., Krienler S.
Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial

Bone (2011), 48: 792-797

Rizzoli R., Kraenzlin M., Krieg M.A., Mellinghoff H.U., Lamy O., Lippuner K.
Indications to teriparatide treatment in patients with osteoporosis

Swiss Med Wkly (2011), 141: w13297

Rizzoli R., Lippuner K., Kraenzlin M., Birkhäuser M.
Osteoporosis in Switzerland in 2011: change since 2008

Rev Med Suisse (2011), 7: 1291-1292

Rohrbach M., Vandersteen A., Yis U., Serdaroglu G., Ataman E., Chopra M., Garcia S., Jones K., Kariminejad A., Kraenzlin M., Marcelis C., Baumgartner M., Giunta C.
Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation

Orphanet J Rare Dis (2011), 6: 46

Suter-Widmer I., Kraenzlin M.E., Meier C.
Primärer Hyperparathyroidismus

Therapeutische Umschau (2011), 68: 321-326

© endonet 2018      gestaltung sabinastucky.ch